<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34871763</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4596</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Free radical biology &amp; medicine</Title><ISOAbbreviation>Free Radic Biol Med</ISOAbbreviation></Journal><ArticleTitle>Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>133</EndPage><MedlinePgn>125-133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2021.11.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0891-5849(21)00829-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, with poor prognosis and no cure. Substantial evidence implicates inflammation and associated oxidative stress as a potential mechanism for ALS, especially in patients carrying the SOD1 mutation and, therefore, lacking anti-oxidant defense. The brain is particularly vulnerable to oxidation due to the abundance of polyunsaturated fatty acids, such as docosahexaenoic acid (DHA), which can give rise to several oxidized metabolites. Accumulation of a DHA peroxidation product, CarboxyEthylPyrrole (CEP) is dependent on activated inflammatory cells and myeloperoxidase (MPO), and thus marks areas of inflammation-associated oxidative stress. At the same time, generation of an alternative inactive DHA peroxidation product, ethylpyrrole, does not require cell activation and MPO activity. While absent in normal brain tissues, CEP is accumulated in the central nervous system (CNS) of ALS patients, reaching particularly high levels in individuals carrying a SOD1 mutation. ALS brains are characterized by high levels of MPO and lowered anti-oxidant activity (due to the SOD1 mutation), thereby aiding CEP generation and accumulation. Due to DHA oxidation within the membranes, CEP marks cells with the highest oxidative damage. In all ALS cases CEP is present in nearly all astrocytes and microglia, however, only in individuals carrying a SOD1 mutation CEP marks &gt;90% of neurons, thereby emphasizing an importance of CEP accumulation as a potential hallmark of oxidative damage in neurodegenerative diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Luyang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCoy</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komuro</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Xiaoxia Z</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakubenko</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Center of Excellence for Inflammation, Infectious Disease and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, 37684, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Detao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudiki</LastName><ForeName>Tejasvi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milo</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podrez</LastName><ForeName>Eugene A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trapp</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byzova</LastName><ForeName>Tatiana V</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. Electronic address: byzovat@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL142772</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL145536</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS097303</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Free Radic Biol Med</MedlineTA><NlmUniqueID>8709159</NlmUniqueID><ISSNLinking>0891-5849</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Carboxyethylpyrrole</Keyword><Keyword MajorTopicYN="N">Lipid peroxidation</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList><CoiStatement>Declaration of Interest: none. Declaration of Interests. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>6</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34871763</ArticleId><ArticleId IdType="mid">NIHMS1763734</ArticleId><ArticleId IdType="pmc">PMC8744315</ArticleId><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.11.031</ArticleId><ArticleId IdType="pii">S0891-5849(21)00829-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rekatsina M, Paladini A, Piroli A, Zis P, Pergolizzi JV, Varrassi G, Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review, Advances in therapy 37(1) (2020) 113&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6979458</ArticleId><ArticleId IdType="pubmed">31782132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH, Amyotrophic lateral sclerosis, Nature reviews. Disease primers 3 (2017) 17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD, Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997&#x2013;2011, Neurology. Clinical practice 3(4) (2013) 313&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ, Oxidative stress in ALS: key role in motor neuron injury and therapeutic target, Free radical biology &amp; medicine 48(5) (2010) 629&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM, C9orf72-mediated ALS and FTD: multiple pathways to disease, Nature reviews. Neurology 14(9) (2018) 544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliesler SJ, Anderson RE, Chemistry and metabolism of lipids in the vertebrate retina, Progress in lipid research 22(2) (1983) 79&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">6348799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakubenko VP, Byzova TV, Biological and pathophysiological roles of end-products of DHA oxidation, Biochimica et biophysica acta. Molecular and cell biology of lipids 1862(4) (2017) 407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360178</ArticleId><ArticleId IdType="pubmed">27713004</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy MG, Nascimento DW, Veleeparambil M, Murtazina R, Gao D, Tkachenko S, Podrez E, Byzova TV, Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis, Sci Signal 14(666) (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112454</ArticleId><ArticleId IdType="pubmed">33986920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakubenko VP, Cui K, Ardell CL, Brown KE, West XZ, Gao D, Stefl S, Salomon RG, Podrez EA, Byzova TV, Oxidative modifications of extracellular matrix promote the second wave of inflammation via &#x3b2;(2) integrins, Blood 132(1) (2018) 78&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034644</ArticleId><ArticleId IdType="pubmed">29724896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YW, Yakubenko VP, West XZ, Gugiu GB, Renganathan K, Biswas S, Gao D, Crabb JW, Salomon RG, Podrez EA, Byzova TV, Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products, Circulation research 117(4) (2015) 321&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522201</ArticleId><ArticleId IdType="pubmed">25966710</ArticleId></ArticleIdList></Reference><Reference><Citation>West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG, Byzova TV, Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands, Nature 467(7318) (2010) 972&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2990914</ArticleId><ArticleId IdType="pubmed">20927103</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigrahi S, Ma Y, Hong L, Gao D, West XZ, Salomon RG, Byzova TV, Podrez EA, Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis, Circulation research 112(1) (2013) 103&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3537845</ArticleId><ArticleId IdType="pubmed">23071157</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG, Drusen proteome analysis: an approach to the etiology of age-related macular degeneration, Proceedings of the National Academy of Sciences of the United States of America 99(23) (2002) 14682&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC137479</ArticleId><ArticleId IdType="pubmed">12391305</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo J, West XZ, Bid HK, Lu L, Hong L, Jang GF, Zhang L, Crabb JW, Linetsky M, Salomon RG, Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs), Chemical research in toxicology 27(12) (2014) 2015&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4269404</ArticleId><ArticleId IdType="pubmed">25380349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, Crabb JW, Salomon RG, Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration, The Journal of biological chemistry 278(43) (2003) 42027&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">12923198</ArticleId></ArticleIdList></Reference><Reference><Citation>Renganathan K, Gu J, Rayborn ME, Crabb JS, Salomon RG, Collier RJ, Kapin MA, Romano C, Hollyfield JG, Crabb JW, CEP biomarkers as potential tools for monitoring therapeutics, PloS one 8(10) (2013) e76325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788138</ArticleId><ArticleId IdType="pubmed">24098476</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S, Xin L, Panigrahi S, Zimman A, Wang H, Yakubenko VP, Byzova TV, Salomon RG, Podrez EA, Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE&#x2212;/&#x2212; mice and activate platelets via TLR2, Blood 127(21) (2016) 2618&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4882806</ArticleId><ArticleId IdType="pubmed">27015965</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui K, Podolnikova NP, Bailey W, Szmuc E, Podrez EA, Byzova TV, Yakubenko VP, Inhibition of integrin &#x3b1;(D)&#x3b2;(2)-mediated macrophage adhesion to end product of docosahexaenoic acid (DHA) oxidation prevents macrophage accumulation during inflammation, The Journal of biological chemistry 294(39) (2019) 14370&#x2013;14382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6768641</ArticleId><ArticleId IdType="pubmed">31395659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarb Y, Weber-Stadlbauer U, Kirschenbaum D, Kindler DR, Richetto J, Keller D, Rademakers R, Dickson DW, Pasch A, Byzova T, Nahar K, Voigt FF, Helmchen F, Boss A, Aguzzi A, Klohs J, Keller A, Ossified blood vessels in primary familial brain calcification elicit a neurotoxic astrocyte response, Brain : a journal of neurology 142(4) (2019) 885&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439320</ArticleId><ArticleId IdType="pubmed">30805583</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 1(5) (2000) 293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettle AJ, Gedye CA, Winterbourn CC, Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide, The Biochemical journal 321 ( Pt 2)(Pt 2) (1997) 503&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1218097</ArticleId><ArticleId IdType="pubmed">9020887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulfaul K, Ozaki E, Fernando N, Brennan K, Chirco KR, Connolly E, Greene C, Maminishkis A, Salomon RG, Linetsky M, Natoli R, Mullins RF, Campbell M, Doyle SL, Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration, Cell reports 30(7) (2020) 2209&#x2013;2224.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179253</ArticleId><ArticleId IdType="pubmed">32075760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ, Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis, Nature reviews. Neurology 7(11) (2011) 616&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P, Amyotrophic lateral sclerosis: a clinical review, European journal of neurology 27(10) (2020) 1918&#x2013;1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, Petrucelli L, Miller BL, Almeida S, Gao FB, Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons, Neuron 92(2) (2016) 383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, Vogel H, Steinberg GK, Edwards MS, Li G, Duncan JA 3rd, Cheshier SH, Shuer LM, Chang EF, Grant GA, Gephart MG, Barres BA, Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse, Neuron 89(1) (2016) 37&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Guilloty F, Saeed AM, Echegaray JJ, Duffort S, Ballmick A, Tan Y, Betancourt M, Viteri E, Ramkhellawan GC, Ewald E, Feuer W, Huang D, Wen R, Hong L, Wang H, Laird JM, Sene A, Apte RS, Salomon RG, Hollyfield JG, Perez VL, Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration, International journal of inflammation 2013 (2013) 503725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606733</ArticleId><ArticleId IdType="pubmed">23533946</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Pope SD, Medzhitov R, Microenvironment controls inflammatory response in macrophages, The Journal of Immunology 206(1 Supplement) (2021) 111.03.</Citation></Reference><Reference><Citation>Neuringer M, Anderson GJ, Connor WE, The essentiality of n-3 fatty acids for the development and function of the retina and brain, Annual review of nutrition 8 (1988) 517&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">3060176</ArticleId></ArticleIdList></Reference><Reference><Citation>Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT, Heinecke JW, Neuronal expression of myeloperoxidase is increased in Alzheimer&#x2019;s disease, Journal of neurochemistry 90(3) (2004) 724&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">15255951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E, Thomas TL, Betmouni S, Scolding N, Love S, Elevated myeloperoxidase activity in white matter in multiple sclerosis, Neuroscience letters 444(2) (2008) 195&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18723077</ArticleId></ArticleIdList></Reference><Reference><Citation>Maki RA, Tyurin VA, Lyon RC, Hamilton RL, DeKosky ST, Kagan VE, Reynolds WF, Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease, The Journal of biological chemistry 284(5) (2009) 3158&#x2013;3169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631957</ArticleId><ArticleId IdType="pubmed">19059911</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke JG, Bogdanik L, Y&#xe1;&#xf1;ez A, Lall D, Wolf AJ, Muhammad AK, Ho R, Carmona S, Vit JP, Zarrow J, Kim KJ, Bell S, Harms MB, Miller TM, Dangler CA, Underhill DM, Goodridge HS, Lutz CM, Baloh RH, C9orf72 is required for proper macrophage and microglial function in mice, Science (New York, N.Y.) 351(6279) (2016) 1324&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, Duong DM, Pennington MW, Lah JJ, Seyfried NT, Levey AI, Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer&#x2019;s disease, Molecular neurodegeneration 13(1) (2018) 24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963076</ArticleId><ArticleId IdType="pubmed">29784049</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD, Differential activation of astrocytes by innate and adaptive immune stimuli, Glia 49(3) (2005) 360&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">15538753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao Y, Qin L, Kim E, Bhosle S, Guo H, Febbraio M, Haskew-Layton RE, Ratan R, Cho S, CD36 is involved in astrocyte activation and astroglial scar formation, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 32(8) (2012) 1567&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3421096</ArticleId><ArticleId IdType="pubmed">22510603</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed AM, Duffort S, Ivanov D, Wang H, Laird JM, Salomon RG, Cruz-Guilloty F, Perez VL, The oxidative stress product carboxyethylpyrrole potentiates TLR2/TLR1 inflammatory signaling in macrophages, PloS one 9(9) (2014) e106421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4153630</ArticleId><ArticleId IdType="pubmed">25184331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J, Halligan E, Baptista MJ, Allen S, Heath PR, Holden H, Barber SC, Loynes CA, Wood-Allum CA, Lunec J, Shaw PJ, Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS, Brain : a journal of neurology 128(Pt 7) (2005) 1686&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang CK, Liu Y, Thomas J, Zhang Y, Zheng XF, Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance, Nature communications 5 (2014) 3446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678626</ArticleId><ArticleId IdType="pubmed">24647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzu P, Blauwendraat C, Heetveld S, Lynes EM, Castillo-Lizardo M, Dhingra A, Pyz E, Hobert M, Synofzik M, Sim&#xf3;n-S&#xe1;nchez J, Francescatto M, Heutink P, C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers, Acta neuropathologica communications 4(1) (2016) 37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4832459</ArticleId><ArticleId IdType="pubmed">27079381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul D, Habbel P, Derkow K, Kr&#xfc;ger C, Franzoni E, Wulczyn FG, Bereswill S, Nitsch R, Schott E, Veh R, Naumann T, Lehnardt S, Expression of Toll-like receptors in the developing brain, PloS one 7(5) (2012) e37767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364272</ArticleId><ArticleId IdType="pubmed">22666391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee P, Winkler CW, Taylor KG, Woods TA, Nair V, Khan BA, Peterson KE, SARM1, Not MyD88, Mediates TLR7/TLR9-Induced Apoptosis in Neurons, Journal of immunology (Baltimore, Md. : 1950) 195(10) (2015) 4913&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769638</ArticleId><ArticleId IdType="pubmed">26423149</ArticleId></ArticleIdList></Reference><Reference><Citation>Maatouk L, Compagnion AC, Sauvage MC, Bemelmans AP, Leclere-Turbant S, Cirotteau V, Tohme M, Beke A, Trichet M, Bazin V, Trawick BN, Ransohoff RM, Tronche F, Manoury B, Vyas S, TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons, Nature communications 9(1) (2018) 2450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015079</ArticleId><ArticleId IdType="pubmed">29934589</ArticleId></ArticleIdList></Reference><Reference><Citation>Acioglu C, Mirabelli E, Baykal AT, Ni L, Ratnayake A, Heary RF, Elkabes S, Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms, Brain, behavior, and immunity 56 (2016) 310&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27044334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M, Cleveland DW, Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond, The Journal of cell biology 187(6) (2009) 761&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A, Lagani&#xe8;re J, Roussel J, Brisebois K, Rouleau GA, Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment, The Journal of neuroscience : the official journal of the Society for Neuroscience 21(10) (2001) 3369&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762496</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW, Onset and progression in inherited ALS determined by motor neurons and microglia, Science (New York, N.Y.) 312(5778) (2006) 1389&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW, Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis, Nature neuroscience 11(3) (2008) 251&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M&#xfc;nch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA, Neurotoxic reactive astrocytes are induced by activated microglia, Nature 541(7638) (2017) 481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, Cottier JP, Roussel C, Kassiou M, Guilloteau D, Ribeiro MJ, Molecular imaging of microglial activation in amyotrophic lateral sclerosis, PloS one 7(12) (2012) e52941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Montal V, Sirisi S, L&#xf3;pez-Pernas G, Cervera-Carles L, Querol-Vilaseca M, Mu&#xf1;oz L, Belbin O, Alcolea D, Molina-Porcel L, Pegueroles J, Tur&#xf3;n-Sans J, Blesa R, Lle&#xf3; A, Fortea J, Rojas-Garc&#xed;a R, Clarim&#xf3;n J, Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis, Neurology(R) neuroimmunology &amp; neuroinflammation 7(5) (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>